Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Markus Leweke

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Brain, Behavior, and Immunity|October 7, 2015
Towards a blood-based diagnostic panel for bipolar disorderFrieder Haenisch, Jason D Cooper, Andreas Reif, et al.
BMJ Open|June 10, 2020
Youth Mental Health Tracker: protocol to establish a longitudinal cohort and research database for young people attending Australian mental health servicesCathrin Rohleder, Yun Ju Christine Song, Jacob J Crouse, et al.
BMJ Open|June 19, 2021
Neurobiology Youth Follow-up Study: protocol to establish a longitudinal and prospective research database using multimodal assessments for current and past mental health treatment-seeking young people within an early intervention serviceAlissa Nichles, Natalia Zmicerevska, Yun Ju Christine Song, et al.
Biomarker Insights|June 4, 2010
Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophreniaEmanuel Schwarz, Rauf Izmailov, Michael Spain, et al.
Science Advances|November 24, 2021
A biomarker-authenticated model of schizophrenia implicating NPTX2 loss of functionMei-Fang Xiao, Seung-Eon Roh, Jiechao Zhou, et al.
BMJ Open|October 11, 2023
EMPOWERED trial: protocol for a randomised control trial of digitally supported, highly personalised and measurement-based care to improve functional outcomes in young people with mood disordersIan B Hickie, Frank Iorfino, Cathrin Rohleder, et al.
Schizophrenia Bulletin|July 20, 2022
Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With SchizophreniaStephan Heres, Joachim Cordes, Sandra Feyerabend, et al.
The American Journal of Psychiatry|December 7, 2016
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and TerminologyOliver D Howes, Rob McCutcheon, Ofer Agid, et al.
The American Journal of Psychiatry|October 8, 2025
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve ThemOliver D Howes, Bernard R Bukala, Eric Y H Chen, et al.
Schizophrenia Bulletin|May 27, 2014
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations, Jim van Os, Bart P Rutten, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Brain, Behavior, and Immunity|October 7, 2015
Towards a blood-based diagnostic panel for bipolar disorderFrieder Haenisch, Jason D Cooper, Andreas Reif, et al.
BMJ Open|June 10, 2020
Youth Mental Health Tracker: protocol to establish a longitudinal cohort and research database for young people attending Australian mental health servicesCathrin Rohleder, Yun Ju Christine Song, Jacob J Crouse, et al.
BMJ Open|June 19, 2021
Neurobiology Youth Follow-up Study: protocol to establish a longitudinal and prospective research database using multimodal assessments for current and past mental health treatment-seeking young people within an early intervention serviceAlissa Nichles, Natalia Zmicerevska, Yun Ju Christine Song, et al.
Biomarker Insights|June 4, 2010
Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophreniaEmanuel Schwarz, Rauf Izmailov, Michael Spain, et al.
Science Advances|November 24, 2021
A biomarker-authenticated model of schizophrenia implicating NPTX2 loss of functionMei-Fang Xiao, Seung-Eon Roh, Jiechao Zhou, et al.
BMJ Open|October 11, 2023
EMPOWERED trial: protocol for a randomised control trial of digitally supported, highly personalised and measurement-based care to improve functional outcomes in young people with mood disordersIan B Hickie, Frank Iorfino, Cathrin Rohleder, et al.
Schizophrenia Bulletin|July 20, 2022
Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With SchizophreniaStephan Heres, Joachim Cordes, Sandra Feyerabend, et al.
The American Journal of Psychiatry|December 7, 2016
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and TerminologyOliver D Howes, Rob McCutcheon, Ofer Agid, et al.
The American Journal of Psychiatry|October 8, 2025
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve ThemOliver D Howes, Bernard R Bukala, Eric Y H Chen, et al.
Schizophrenia Bulletin|May 27, 2014
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations, Jim van Os, Bart P Rutten, et al.
Pageof 12